Stephens Inc Cerus Corp Transaction History

Stephens Inc

$7.43 Billion
Q3 2025

A detailed history of Stephens Inc transactions in Cerus Corp stock. As of the latest transaction made, Stephens Inc holds 98,491 shares of CERS stock, worth $137,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares

98,491

Previous 110,294 10.7%

Holding current value

$137,887

Previous $155,000 0.65%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	SELL	$1.16 - $1.6 $13,691 - $18,884	-11,803 Reduced 10.7%	98,491 $156,000
Q2 2025 Jul 29, 2025	BUY	$1.22 - $1.51 $10,870 - $13,454	8,910 Added 8.79%	110,294 $155,000
Q1 2025 May 01, 2025	SELL	$1.39 - $2.15 $507 - $784	-365 Reduced 0.36%	101,384 $140,000
Q4 2024 Jan 28, 2025	BUY	$1.52 - $2.03 $5,441 - $7,267	3,580 Added 3.65%	101,749 $156,000
Q3 2024 Oct 28, 2024	SELL	$1.7 - $2.39 $25,134 - $35,336	-14,785 Reduced 13.09%	98,169 $170,000
Q2 2024 Aug 06, 2024	SELL	$1.62 - $2.04 $5,184 - $6,528	-3,200 Reduced 2.75%	112,954 $198,000
Q1 2024 May 15, 2024	SELL	$1.66 - $2.42 $75,820 - $110,533	-45,675 Reduced 28.22%	116,154 $219,000
Q4 2023 Feb 13, 2024	SELL	$1.25 - $2.35 $134,936 - $253,680	-107,949 Reduced 40.01%	161,829 $349,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.07 $19,258 - $39,415	12,839 Added 5.0%	269,778 $437,000
Q2 2023 Aug 14, 2023	SELL	$1.79 - $2.9 $20,209 - $32,741	-11,290 Reduced 4.21%	256,939 $632,000
Q1 2023 May 15, 2023	SELL	$2.65 - $3.81 $970,313 - $1.4 Million	-366,156 Reduced 57.72%	268,229 $796,000
Q4 2022 Jan 25, 2023	SELL	$3.38 - $4.22 $57,493 - $71,782	-17,010 Reduced 2.61%	634,385 $2.32 Million
Q3 2022 Nov 02, 2022	SELL	$3.43 - $5.83 $35,329 - $60,049	-10,300 Reduced 1.56%	651,395 $2.35 Million
Q2 2022 Aug 03, 2022	BUY	$4.41 - $5.69 $18,411 - $23,755	4,175 Added 0.63%	661,695 $3.5 Million
Q1 2022 May 04, 2022	SELL	$4.81 - $6.99 $15,560 - $22,612	-3,235 Reduced 0.49%	657,520 $3.61 Million
Q4 2021 Mar 07, 2022	BUY	$5.97 - $7.93 $78,236 - $103,922	13,105 Added 2.02%	660,755 $4.5 Million
Q3 2021 Oct 27, 2021	BUY	$4.79 - $6.68 $99,392 - $138,610	20,750 Added 3.31%	647,650 $3.94 Million
Q2 2021 Aug 12, 2021	BUY	$5.35 - $6.35 $238,369 - $282,924	44,555 Added 7.65%	626,900 $3.71 Million
Q1 2021 May 14, 2021	BUY	$5.68 - $7.87 $430,055 - $595,869	75,714 Added 14.94%	582,345 $3.5 Million
Q4 2020 Feb 10, 2021	SELL	$5.25 - $8.56 $290,193 - $473,154	-55,275 Reduced 9.84%	506,631 $3.51 Million
Q3 2020 Nov 13, 2020	SELL	$5.78 - $7.47 $1.42 Million - $1.83 Million	-245,491 Reduced 30.41%	561,906 $3.52 Million
Q2 2020 Aug 24, 2020	SELL	$4.5 - $7.02 $346,914 - $541,185	-77,092 Reduced 8.72%	807,397 $5.33 Million
Q1 2020 May 14, 2020	SELL	$2.87 - $5.49 $71,907 - $137,551	-25,055 Reduced 2.75%	884,489 $4.11 Million
Q4 2019 Feb 14, 2020	SELL	$3.84 - $4.86 $116,843 - $147,880	-30,428 Reduced 3.24%	909,544 $3.84 Million
Q3 2019 Oct 18, 2019	BUY	$4.86 - $6.05 $148,968 - $185,444	30,652 Added 3.37%	939,972 $4.85 Million
Q2 2019 Aug 01, 2019	BUY	$4.51 - $6.6 $639,098 - $935,266	141,707 Added 18.46%	909,320 $5.11 Million
Q1 2019 May 03, 2019	BUY	$5.16 - $6.85 $166,471 - $220,994	32,262 Added 4.39%	767,613 $4.78 Million
Q4 2018 Feb 11, 2019	BUY	$4.89 - $7.16 $397,439 - $581,936	81,276 Added 12.43%	735,351 $3.73 Million
Q3 2018 Nov 14, 2018	BUY	$6.89 - $7.78 $4.51 Million - $5.09 Million	654,075 New	654,075 $4.72 Million
Q3 2017 Nov 08, 2017	SELL	$2.22 - $2.73 $2.14 Million - $2.63 Million	-963,702 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	963,702	963,702 $2.42 Million

Others Institutions Holding CERS

# of Institutions

164

Shares Held

139M

Call Options Held

100K

Put Options Held

16K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $248M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account